9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid | 161802-07-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: 9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid
• 英文别名: 5,8-Dimethoxy-9,10-dioxoanthracene-2-carboxylic acid
• CAS: 161802-07-9
• 化学式: C₁₇H₁₂O₆
• 分子量: 312.279
• InChiKey: GKTYFTLQOWTUFY-UHFFFAOYSA-N

物化性质

• 沸点：
  577.1±50.0 °C(Predicted)
• 密度：
  1.421±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  89.9
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid 在 吡啶 、 氯化亚砜 作用下， 以 various solvent(s) 为溶剂， 反应 0.5h， 生成 9,10-Dihydro-5,8-dimethoxy-N-(1,1-dimethylethyl)-9,10-dioxoanthracene-2-carboxamide
  参考文献：
  名称：

  Anthraquinones related to rhein inhibit glucose uptake into chondrocytes. A mechanism for anti-osteoarthritis drugs?

  摘要：

  Rhein has been shown to inhibit the uptake of glucose into Ehrlich Ascites tumor cells. In this paper we show that a wide range of anthraquinones related to rhein can also inhibit glucose uptake into chondrocytes, many significantly more than the parent molecule. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00102-9
• 作为产物：
  描述：

  偏苯三酸酐 在 sodium hydroxide 、 三氯化铝 、 水 、 potassium carbonate 、 sodium chloride 作用下， 反应 2.0h， 生成 9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid
  参考文献：
  名称：

  Anthraquinones related to rhein inhibit glucose uptake into chondrocytes. A mechanism for anti-osteoarthritis drugs?

  摘要：

  Rhein has been shown to inhibit the uptake of glucose into Ehrlich Ascites tumor cells. In this paper we show that a wide range of anthraquinones related to rhein can also inhibit glucose uptake into chondrocytes, many significantly more than the parent molecule. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00102-9

文献信息

• Pharmaceutical compounds
  申请人：Eli Lilly and Company

  公开号：US05430067A1

  公开（公告）日：1995-07-04

  Pharmaceutical compounds as follows: 9,10-dihydro-9,10-dioxo-4,5,8-trimethoxyanthracene-2-carboxylic acid, 4,5-diethoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid, 9,10-dihydro-9,10-dioxo-4,5-dipropoxyanthracene-2-carboxylic acid, 4,5-dibutoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid, 9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid, 7-acetoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid; and salts and esters thereof.

  以下是药物化合物的中文翻译：9,10-二氢-9,10-二氧-4,5,8-三甲氧基蒽-2-羧酸，4,5-二乙氧基-9,10-二氢-9,10-二氧基蒽-2-羧酸，9,10-二氢-9,10-二氧-4,5-二丙氧基蒽-2-羧酸，4,5-二丁氧基-9,10-二氢-9,10-二氧基蒽-2-羧酸，9,10-二氢-5,8-二甲氧基-9,10-二氧基蒽-2-羧酸，7-乙酰氧基-9,10-二氢-9,10-二氧基蒽-2-羧酸；及其盐和酯。
• Pharmaceutical anthracene-2-carboxylic acid derivatives
  申请人：LILLY INDUSTRIES LIMITED

  公开号：EP0638540A1

  公开（公告）日：1995-02-15

  Pharmaceutical compounds as follows: 9,10-dihydro-9,10-dioxo-4,5,8-trimethoxyanthracene-2-carboxylic acid, 4,5-diethoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid, 9,10-dihydro-9,10-dioxo-4,5-dipropoxyanthracene-2-carboxylic acid, 4,5-dibutoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid, 9,10-dihydro-5,8-dimethoxy-9,10-dioxoanthracene-2-carboxylic acid, 7-acetoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid; and salts and esters thereof.

  药用化合物如下 9,10-二氢-9,10-二氧代-4,5,8-三甲氧基蒽-2-羧酸、 4,5-二乙氧基-9,10-二氢-9,10-二氧代蒽-2-羧酸、 9,10-二氢-9,10-二氧代-4,5-二丙氧基蒽-2-羧酸、 4,5-二丁氧基-9,10-二氢-9,10-二氧代蒽-2-羧酸 9,10-二氢-5,8-二甲氧基-9,10-二氧代蒽-2-羧酸、 7-乙酰氧基-9,10-二氢-9,10-二氧代蒽-2-羧酸； 及其盐类和酯类。
• Anthraquinone derivatives useful in the treatment of cancer and osteoartritis
  申请人：LILLY INDUSTRIES LIMITED

  公开号：EP0638562A1

  公开（公告）日：1995-02-15

  Pharmaceutical compounds of the formula in which R¹ and R³ are each C₁₋₄ alkyl or C₁₋₄ alkyl-carbonyl, and R² is carboxy, tetrazolyl, C₁₋₄ alkyl-sulphonamido or -CR⁴R⁵CO₂H where R⁴ and R⁵ are each hydrogen or C₁₋₄ alkyl; provided that when R¹ and R³ are both methyl and when R¹ and R³ are both methylcarbonyl, R² is not carboxy; and salts and esters thereof.

  式中的药物化合物 其中 R¹ 和 R³ 各为 C₁₋₄ 烷基或 C₁₋₄ 烷基-羰基，R² 为羧基、四唑基、C₁₋₄ 烷基-磺酰胺基或-CR⁴R⁵CO₂H，其中 R⁴ 和 R⁵ 各为氢或 C₁₋₄ 烷基；但当 R¹ 和 R³ 都是甲基和当 R¹ 和 R³ 都是甲基羰基时，R² 不是羧基；以及它们的盐和酯。
• JPH0776553A
  申请人：——

  公开号：JPH0776553A

  公开（公告）日：1995-03-20
• US5430067A
  申请人：——

  公开号：US5430067A

  公开（公告）日：1995-07-04